Dashboard
Manage Tickers

XOMAXOMA Corp

Nasdaq xoma.com


$ 28.04 $ 0.22 (0.79 %)    

Friday, 16-Aug-2024 15:45:37 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 475.24 $ 3.66 (0.78 %)
DIA $ 406.80 $ 0.86 (0.21 %)
SPY $ 554.24 $ 1.17 (0.21 %)
TLT $ 97.41 $ 0.31 (0.32 %)
GLD $ 231.90 $ 4.99 (2.2 %)
$ 28.13
$ 27.61
$ 27.75 x 100
-- x --
$ 27.61 - $ 28.73
$ 13.48 - $ 30.36
18,507
na
319.12M
$ 0.85
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-08-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-09-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 03-08-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 03-10-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-05-2020 03-31-2020 10-Q
19 03-10-2020 12-31-2019 10-K
20 11-05-2019 09-30-2019 10-Q
21 08-06-2019 06-30-2019 10-Q
22 05-06-2019 03-31-2019 10-Q
23 03-07-2019 12-31-2018 10-K
24 11-07-2018 09-30-2018 10-Q
25 08-07-2018 06-30-2018 10-Q
26 05-09-2018 03-31-2018 10-Q
27 03-07-2018 12-31-2017 10-K
28 11-06-2017 09-30-2017 10-Q
29 08-08-2017 06-30-2017 10-Q
30 05-09-2017 03-31-2017 10-Q
31 03-16-2017 12-31-2016 10-K
32 11-09-2016 09-30-2016 10-Q
33 08-03-2016 06-30-2016 10-Q
34 05-04-2016 03-31-2016 10-Q
35 03-09-2016 12-31-2015 10-K
36 11-06-2015 09-30-2015 10-Q
37 08-10-2015 06-30-2015 10-Q
38 05-07-2015 03-31-2015 10-Q
39 03-11-2015 12-31-2014 10-K
40 11-06-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-maintains-buy-on-xoma-royalty-raises-price-target-to-117
HC Wainwright & Co. Maintains Buy on XOMA ...
08/15/2024 10:22:21

HC Wainwright & Co. analyst Joseph Pantginis maintains XOMA Royalty (NASDAQ:XOMA) with a Buy and raises the price target...

xoma-q2-2024-gaap-eps-084-beats-027-estimate-sales-11086m-beat-8377m-estimate
XOMA Q2 2024 GAAP EPS $0.84 Beats $(0.27) ...
08/13/2024 11:36:10

fda-convenes-expert-panel-meeting-for-zevra-therapeutics-arimoclomol-analyst-optimistic-about-approval-despite-small-patient-base
FDA Convenes Expert Panel Meeting For Zevr...
07/09/2024 19:27:21

FDA's Genetic Metabolic Diseases Advisory Committee will review Zevra Therapeutics' arimoclomol for Niemann-Pick diseas...

demystifying-xoma-insights-from-5-analyst-reviews
Demystifying XOMA: Insights From 5 Analyst...
07/09/2024 14:01:08

hc-wainwright--co-reiterates-buy-on-xoma-maintains-74-price-target
HC Wainwright & Co. Reiterates Buy on XOMA...
07/09/2024 10:28:15

HC Wainwright & Co. analyst Joseph Pantginis reiterates XOMA (NASDAQ:XOMA) with a Buy and maintains $74 price target.

xoma-disclosed-it-had-received-an-81m-milestone-payment-from-viracta-therapeutics-inc-related-to-day-one-biopharmaceuticals-recent-sale-of-its-priority-review-voucher-prv-for-108mto-an-undisclosed-buyer
XOMA Disclosed It Had Received An $8.1M Mi...
06/12/2024 11:32:30

peeling-back-the-layers-exploring-xoma-through-analyst-insights
Peeling Back The Layers: Exploring XOMA Th...
05/31/2024 12:00:43

hc-wainwright--co-reiterates-buy-on-xoma-maintains-74-price-target
HC Wainwright & Co. Reiterates Buy on XOMA...
05/31/2024 10:49:15

HC Wainwright & Co. analyst Joseph Pantginis reiterates XOMA (NASDAQ:XOMA) with a Buy and maintains $74 price target.

xoma-q1-2024-gaap-eps-086-misses-081-estimate
XOMA Q1 2024 GAAP EPS $(0.86) Misses $(0.8...
05/09/2024 12:38:26

XOMA (NASDAQ:XOMA) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $(0.81) by 6.1...

hc-wainwright--co-reiterates-buy-on-xoma-maintains-74-price-target
HC Wainwright & Co. Reiterates Buy on XOMA...
05/01/2024 11:03:52

HC Wainwright & Co. analyst Joseph Pantginis reiterates XOMA (NASDAQ:XOMA) with a Buy and maintains $74 price target.

Core News & Articles
Xoma Has Acquired An Economic Interest In ...
04/30/2024 11:36:17

Organon, a global women's healthcare company, initiated XACIATO commercial activities in the fourth quarter of 2023. XOM...

cracking-the-code-understanding-analyst-reviews-for-xoma
Cracking The Code: Understanding Analyst R...
04/29/2024 14:00:22

leerink-partners-initiates-coverage-on-xoma-with-outperform-rating-announces-price-target-of-40
Leerink Partners Initiates Coverage On XOM...
04/29/2024 12:54:28

Leerink Partners analyst Jason Zhuang initiates coverage on XOMA (NASDAQ:XOMA) with a Outperform rating and announces Price ...

xoma-earns-9m-as-fda-grants-accelerated-approval-to-day-ones-ojemda-tovorafenib-for-relapsed-or-refractory-braf-altered-pediatric-low-grade-glioma
Xoma Earns $9M As FDA Grants Accelerated A...
04/25/2024 12:07:05

hc-wainwright--co-reiterates-buy-on-xoma-maintains-74-price-target
HC Wainwright & Co. Reiterates Buy on XOMA...
04/25/2024 11:23:10

HC Wainwright & Co. analyst Joseph Pantginis reiterates XOMA (NASDAQ:XOMA) with a Buy and maintains $74 price target.

Core News & Articles
XOMA Corp Entered Into A Merger Agreement ...
03/19/2024 20:15:36

As previously announced on February 16, 2024, XOMA Corporation (("XOMA" or the "Company", NASDAQ:XOMA) entered ...

hc-wainwright--co-maintains-buy-on-xoma-maintains-74-price-target
HC Wainwright & Co. Maintains Buy on XOMA,...
03/11/2024 16:10:48

HC Wainwright & Co. analyst Joseph Pantginis maintains XOMA (NASDAQ:XOMA) with a Buy and maintains $74 price target.

recap-xoma-q4-earnings
Recap: XOMA Q4 Earnings
03/08/2024 12:40:05

xoma-fy-gaap-eps-404-may-not-be-comparable-to-205-estimate-sales-476m-miss-650m-estimate
XOMA FY GAAP EPS $(4.04) May Not Be Compar...
03/08/2024 12:35:50

XOMA (NASDAQ:XOMA) reported quarterly losses of $(4.04) per share which missed the analyst consensus estimate of $(2.05) by 97....

hc-wainwright--co-reiterates-buy-on-xoma-maintains-74-price-target
HC Wainwright & Co. Reiterates Buy on XOMA...
02/16/2024 18:41:43

HC Wainwright & Co. analyst Joseph Pantginis reiterates XOMA (NASDAQ:XOMA) with a Buy and maintains $74 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION